Literature DB >> 31085515

Independent Host Factors and Bacterial Genetic Determinants of the Emergence and Dominance of Escherichia coli Sequence Type 131 CTX-M-27 in a Community Pediatric Cohort Study.

André Birgy1, Corinne Levy2,3,4, Marie-Hélène Nicolas-Chanoine5, Aurélie Cointe1, Claire A Hobson5, Mélanie Magnan5, Stéphane Bechet2, Philippe Bidet1, Robert Cohen2,3,4,6, Stéphane Bonacorsi7.   

Abstract

The recent emergence and diffusion in the community of Escherichia coli isolates belonging to the multidrug-resistant and CTX-M-27-producing sequence type 131 (ST131) C1-M27 cluster makes this cluster potentially as epidemic as the worldwide E. coli ST131 subclade C2 composed of multidrug-resistant isolates producing CTX-M-15. Thirty-five extended-spectrum beta-lactamase (ESBL)-producing ST131 isolates were identified in a cohort of 1,885 French children over a 5-year period. They were sequenced to characterize the ST131 E. coli isolates producing CTX-M-27 recently emerging in France. ST131 isolates producing CTX-M-27 (n = 17), and particularly those belonging to the C1-M27 cluster (n = 14), carried many resistance-encoding genes and predominantly an F1:A2:B20 plasmid type. In multivariate analysis, having been hospitalized since birth (odds ratio [OR], 10.9; 95% confidence interval [CI], 2.4 to 48.8; P = 0.002) and being cared for in a day care center (OR, 9.4; 95% CI, 1.5 to 59.0; P = 0.017) were independent risk factors for ST131 CTX-M-27 fecal carriage compared with ESBL-producing non-ST131 isolates. No independent risk factor was found when comparing CTX-M-15 (n = 11)- and CTX-M-1/14 (n = 7)-producing ST131 isolates with ESBL-producing non-ST131 isolates or with non-ESBL-producing isolates. Several factors may contribute to the increase in fecal carriage of CTX-M-27-producing E. coli isolates, namely, resistance to multiple antibiotics, capacity of the CTX-M-27 enzyme to hydrolyze both cefotaxime and ceftazidime, carriage of a peculiar F-type plasmid, and/or capacity to colonize children who have been hospitalized since birth or who attend day care centers.
Copyright © 2019 American Society for Microbiology.

Entities:  

Keywords:  C1-M27; CTX-M-27; E. colizzm321990; ESBL; ST131; children; fecal carriage; risk factors

Year:  2019        PMID: 31085515      PMCID: PMC6591637          DOI: 10.1128/AAC.00382-19

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  40 in total

1.  Characterization of human uropathogenic ESBL-producing Escherichia coli in the Czech Republic: spread of CTX-M-27-producing strains in a university hospital.

Authors:  Lenka Micenková; Petra Sišková; Juraj Bosák; Ivana Jamborová; Lenka Cernohorská; David Smajs
Journal:  Microb Drug Resist       Date:  2014-12       Impact factor: 3.431

2.  Extensive Genetic Commonality among Wildlife, Wastewater, Community, and Nosocomial Isolates of Escherichia coli Sequence Type 131 (H30R1 and H30Rx Subclones) That Carry blaCTX-M-27 or blaCTX-M-15.

Authors:  Ivana Jamborova; Brian D Johnston; Ivo Papousek; Katerina Kachlikova; Lenka Micenkova; Connie Clabots; Anna Skalova; Katerina Chudejova; Monika Dolejska; Ivan Literak; James R Johnson
Journal:  Antimicrob Agents Chemother       Date:  2018-09-24       Impact factor: 5.191

3.  CTX-M-27- and CTX-M-14-producing, ciprofloxacin-resistant Escherichia coli of the H30 subclonal group within ST131 drive a Japanese regional ESBL epidemic.

Authors:  Yasufumi Matsumura; James R Johnson; Masaki Yamamoto; Miki Nagao; Michio Tanaka; Shunji Takakura; Satoshi Ichiyama
Journal:  J Antimicrob Chemother       Date:  2015-02-16       Impact factor: 5.790

4.  Emergence of ESBL-producing Escherichia coli ST131-C1-M27 clade colonizing patients in Europe.

Authors:  Irene Merino; Marta Hernández-García; María-Carmen Turrientes; Blanca Pérez-Viso; Nieves López-Fresneña; Cristina Diaz-Agero; Friederike Maechler; Carolina Fankhauser-Rodriguez; Axel Kola; Jacques Schrenzel; Stephan Harbarth; Marc Bonten; Petra Gastmeier; R Canton; P Ruiz-Garbajosa
Journal:  J Antimicrob Chemother       Date:  2018-11-01       Impact factor: 5.790

5.  Effect of D240G substitution in a novel ESBL CTX-M-27.

Authors:  R Bonnet; C Recule; R Baraduc; C Chanal; D Sirot; C De Champs; J Sirot
Journal:  J Antimicrob Chemother       Date:  2003-05-29       Impact factor: 5.790

6.  ESBL-producing Escherichia coli ST131 versus non-ST131: evolution and risk factors of carriage among French children in the community between 2010 and 2015.

Authors:  André Birgy; Corinne Levy; Philippe Bidet; Franck Thollot; Véronique Derkx; Stéphane Béchet; Patricia Mariani-Kurkdjian; Robert Cohen; Stéphane Bonacorsi
Journal:  J Antimicrob Chemother       Date:  2016-06-20       Impact factor: 5.790

7.  Solving the problem of comparing whole bacterial genomes across different sequencing platforms.

Authors:  Rolf S Kaas; Pimlapas Leekitcharoenphon; Frank M Aarestrup; Ole Lund
Journal:  PLoS One       Date:  2014-08-11       Impact factor: 3.240

8.  Virulence patterns in a murine sepsis model of ST131 Escherichia coli clinical isolates belonging to serotypes O25b:H4 and O16:H5 are associated to specific virotypes.

Authors:  Azucena Mora; Ghizlane Dahbi; Cecilia López; Rosalía Mamani; Juan Marzoa; Sara Dion; Bertrand Picard; Miguel Blanco; María Pilar Alonso; Erick Denamur; Jorge Blanco
Journal:  PLoS One       Date:  2014-01-30       Impact factor: 3.240

9.  The epidemic of extended-spectrum-β-lactamase-producing Escherichia coli ST131 is driven by a single highly pathogenic subclone, H30-Rx.

Authors:  Lance B Price; James R Johnson; Maliha Aziz; Connie Clabots; Brian Johnston; Veronika Tchesnokova; Lora Nordstrom; Maria Billig; Sujay Chattopadhyay; Marc Stegger; Paal S Andersen; Talima Pearson; Kim Riddell; Peggy Rogers; Delia Scholes; Barbara Kahl; Paul Keim; Evgeni V Sokurenko
Journal:  mBio       Date:  2013-12-17       Impact factor: 7.867

10.  Systematic longitudinal survey of invasive Escherichia coli in England demonstrates a stable population structure only transiently disturbed by the emergence of ST131.

Authors:  Teemu Kallonen; Hayley J Brodrick; Simon R Harris; Jukka Corander; Nicholas M Brown; Veronique Martin; Sharon J Peacock; Julian Parkhill
Journal:  Genome Res       Date:  2017-07-18       Impact factor: 9.043

View more
  7 in total

1.  Characterization of bla CTX-M-27/F1:A2:B20 Plasmids Harbored by Escherichia coli Sequence Type 131 Sublineage C1/H30R Isolates Spreading among Elderly Japanese in Nonacute-Care Settings.

Authors:  Nao Matsuo; Rina Nonogaki; Michiko Hayashi; Jun-Ichi Wachino; Masahiro Suzuki; Yoshichika Arakawa; Kumiko Kawamura
Journal:  Antimicrob Agents Chemother       Date:  2020-04-21       Impact factor: 5.191

2.  Genomic insights of high-risk clones of ESBL-producing Escherichia coli isolated from community infections and commercial meat in southern Brazil.

Authors:  João Gabriel Material Soncini; Louise Cerdeira; Elder Sano; Vanessa Lumi Koga; Ariane Tiemy Tizura; Zuleica Naomi Tano; Gerson Nakazato; Renata Katsuko Takayama Kobayashi; Caio Augusto Martins Aires; Nilton Lincopan; Eliana Carolina Vespero
Journal:  Sci Rep       Date:  2022-06-07       Impact factor: 4.996

3.  Improved Molecular Diagnosis and Culture of the Emerging Heteropathotype Enterohemorrhagic Escherichia coli O80:H2 Using Its Non-Melibiose-Fermenting and Antibiotic-Resistance Properties.

Authors:  Etienne Bizot; Aurélie Cointe; Natacha Smadja; Delphine Sergentet; Sophie Lefèvre; François-Xavier Weill; Corinne Levy; Robert Cohen; Patricia Mariani-Kurkdjian; Stéphane Bonacorsi
Journal:  J Clin Microbiol       Date:  2021-09-29       Impact factor: 11.677

4.  Arrangements of Mobile Genetic Elements among Virotype E Subpopulation of Escherichia coli Sequence Type 131 Strains with High Antimicrobial Resistance and Virulence Gene Content.

Authors:  Omid Pajand; Hamzeh Rahimi; Narges Darabi; Solaleh Roudi; Khatereh Ghassemi; Frank M Aarestrup; Pimlapas Leekitcharoenphon
Journal:  mSphere       Date:  2021-08-25       Impact factor: 4.389

5.  Genomic comparisons of Escherichia coli ST131 from Australia.

Authors:  Dmitriy Li; Ethan R Wyrsch; Paarthiphan Elankumaran; Monika Dolejska; Marc S Marenda; Glenn F Browning; Rhys N Bushell; Jessica McKinnon; Piklu Roy Chowdhury; Nola Hitchick; Natalie Miller; Erica Donner; Barbara Drigo; Dave Baker; Ian G Charles; Timothy Kudinha; Veronica M Jarocki; Steven Philip Djordjevic
Journal:  Microb Genom       Date:  2021-12

6.  Community Fecal Carriage and Molecular Epidemiology of Extended-Spectrum β-Lactamase- and Carbapenemase-Producing Escherichia coli from Healthy Children in the Central South China.

Authors:  Xuan Liu; Xin Li; A-Wen Yang; Bin Tang; Zi-Juan Jian; Yi-Ming Zhong; Hong-Ling Li; Yan-Ming Li; Qun Yan; Xiang-Hui Liang; Wen-En Liu
Journal:  Infect Drug Resist       Date:  2022-04-06       Impact factor: 4.003

7.  Global Evolution of Pathogenic Bacteria With Extensive Use of Fluoroquinolone Agents.

Authors:  Miklos Fuzi; Jesus Rodriguez Baño; Akos Toth
Journal:  Front Microbiol       Date:  2020-02-25       Impact factor: 5.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.